Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 26.80 INR
Change Today -0.30 / -1.11%
Volume 14.9K
As of 6:00 AM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

sandu pharmaceuticals (SNDP) Snapshot

Open
27.90
Previous Close
27.10
Day High
28.75
Day Low
22.00
52 Week High
05/21/15 - 33.70
52 Week Low
07/9/14 - 10.62
Market Cap
189.8M
Average Volume 10 Days
4.9K
EPS TTM
0.58
Shares Outstanding
7.1M
EX-Date
--
P/E TM
45.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for SANDU PHARMACEUTICALS (SNDP)

Related News

No related news articles were found.

sandu pharmaceuticals (SNDP) Related Businessweek News

No Related Businessweek News Found

sandu pharmaceuticals (SNDP) Details

Sandu Pharmaceuticals Limited manufactures and markets ayurvedic medicines primarily in India and internationally. The company offers medicines in the areas of cardiovascular systems, endocrine systems, digestive systems, genito-urinary systems, muscular skeletal systems, nervous systems, male reproductive systems, respiratory systems, and nutrition. It also provides medicines for gynaecological; skin; and ear, nose, and throat disorders. The company was founded in 1899 and is based in Mumbai, India.

Founded in 1899

sandu pharmaceuticals (SNDP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sandu pharmaceuticals (SNDP) Key Developments

Sandu Pharmaceuticals Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015

Sandu Pharmaceuticals Limited reported audited standalone earnings results for the fourth quarter and full year ended March 31, 2015. For the quarter, net sales/income from operation was INR 128.156 million against INR 110.395 million a year ago. Profit from operation before other income, finance costs and exceptional items was INR 3.118 million against INR 5.018 million a year ago. Profit from ordinary activities before tax was INR 0.307 million against INR 3.837 million a year ago. Net loss was INR 0.492 million or INR 0.07 per basic and diluted share against profit of INR 1.705 million or INR 0.24 per basic and diluted share a year ago.   For the year, net sales/income from operation was INR 444.030 million against INR 402.279 million a year ago. Profit from operation before other income, finance costs and exceptional items was INR 18.620 million against INR 15.519 million a year ago. Profit from ordinary activities before tax was INR 6.287 million against INR 8.232 million a year ago. Net profit was INR 4.137 million or INR 0.58 per basic and diluted share against INR 4.962 million or INR 0.70 per basic and diluted share a year ago.

Sandu Pharmaceuticals Ltd Names Pratika Desai as Company Secretary and Compliance Officer

Sandu Pharmaceuticals Ltd. announced that the board of directors of the company at its meeting held on March 30, 2015, has appointed Miss. Pratika Desai as the company secretary and compliance officer of the company with effect from April 01, 2015.

Sandu Pharmaceuticals Limited Appoints Shubhada P. Sandu as Woman Director

Sandu Pharmaceuticals Ltd has announced that the board of directors of the company at its meeting held on March 30, 2015, has appointed Dr. Mrs. Shubhada P. Sandu as the woman director of the company with effect from April 01, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNDP:IN 26.80 INR -0.30

SNDP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SNDP.
View Industry Companies
 

Industry Analysis

SNDP

Industry Average

Valuation SNDP Industry Range
Price/Earnings 45.3x
Price/Sales 0.5x
Price/Book 1.0x
Price/Cash Flow 18.8x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANDU PHARMACEUTICALS, please visit www.sandu.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.